Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eva K Roth"'
Autor:
Yang Zhou, Partho Sarothi Ray, Jianguo Zhu, Frank Stein, Mandy Rettel, Thileepan Sekaran, Sudeep Sahadevan, Joel I. Perez-Perri, Eva K. Roth, Ola Myklebost, Leonardo A. Meza-Zepeda, Andreas von Deimling, Chuli Fu, Annika N. Brosig, Kjetil Boye, Michaela Nathrath, Claudia Blattmann, Burkhard Lehner, Matthias W. Hentze, Andreas E. Kulozik
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-22 (2024)
Abstract Osteosarcoma is the most common primary malignant bone tumor with a strong tendency to metastasize, limiting the prognosis of affected patients. Genomic, epigenomic and transcriptomic analyses have demonstrated the exquisite molecular comple
Externí odkaz:
https://doaj.org/article/c8a044416b63443ebe99465720d460f3
Autor:
Eva K Roth, Stephanie Hirtz, Julia Duerr, Daniel Wenning, Irmgard Eichler, Hans H Seydewitz, Margarida D Amaral, Marcus A Mall
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e24445 (2011)
BACKGROUND: The identification of strategies to improve mutant CFTR function remains a key priority in the development of new treatments for cystic fibrosis (CF). Previous studies demonstrated that the K⁺ channel opener 1-ethyl-2-benzimidazolone (1
Externí odkaz:
https://doaj.org/article/0d44ba32aac148c392d7c0607cb9a8f9
Autor:
Marco Francesco Morini, Claudia Blattmann, Eva K. Roth, Mandy L. Ballinger, David Thomas, Karl Heinimann, Ian Tomlinson, Andreas E. Kulozik, Michaela Nathrath, Monika Kovacova, Baptiste Ameline, Sebastian Ribi, Wolfgang Hartmann, Michal Kovac, Connor Woolley, Daniel Baumhoer, Stefan S. Bielack
Publikováno v:
Journal of Medical Genetics. 58:20-24
BackgroundAlthough considerable effort has been put into decoding of the osteosarcoma genome, very little is known about germline mutations that underlie this primary malignant tumour of bone.Methods and resultsWe followed here a coincidental finding
Autor:
Markus Thiemann, Peter E. Huber, Christopher L Heidler, Eva K Roth, Michal Kovac, Beate Amthor, Claudia Blattmann, Gabriele Neu-Yilik, Ramon Lopez Perez, Andreas E. Kulozik
Publikováno v:
International Journal of Cancer
Progress in the systemic control of osteosarcoma has been limited over the past decades thus indicating the urgent clinical need for the development of novel treatment strategies. Therefore, we have recently developed new preclinical models to study
Autor:
Petra Pavel, Anita Schmitt, Eva K. Roth, Johann Greil, Joachim B. Kunz, Alexander Kunz, Michael Schmitt, Andreas E. Kulozik, Adil Mirza
Publikováno v:
Transplantation and Cellular Therapy. 28:S227-S228
Background Beti-cel ex vivo gene therapy integrates a modified HBB gene into hematopoietic stem cells of patients with TDT, aiming to enable lifelong, stable production of functional adult hemoglobin (Hb). The efficacy and safety of the treatment hav
Autor:
Margarida D. Amaral, Julia Duerr, Hans H. Seydewitz, Eva K. Roth, Daniel Wenning, Marcus A. Mall, Irmgard Eichler, Stephanie Hirtz
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e24445 (2011)
PLoS ONE
PLoS ONE
BACKGROUND: The identification of strategies to improve mutant CFTR function remains a key priority in the development of new treatments for cystic fibrosis (CF). Previous studies demonstrated that the K⁺ channel opener 1-ethyl-2-benzimidazolone (1